High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
about
Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethalityContribution of the Type II Chaperonin, TRiC/CCT, to OncogenesisPleiotropic role of HSF1 in neoplastic transformationHeat-shock factor 2 is a suppressor of prostate cancer invasion.IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesismTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesisUncoupling Stress-Inducible Phosphorylation of Heat Shock Factor 1 from Its ActivationHeat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an updatePhotothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular spaceTransportable, Chemical Genetic Methodology for the Small Molecule-Mediated Inhibition of Heat Shock Factor 1Expression of HSF2 decreases in mitosis to enable stress-inducible transcription and cell survival.Overexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinomaHER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancerIntegrin-linked kinase modulates longevity and thermotolerance in C. elegans through neuronal control of HSF-1.IER5 as a promising predictive marker promotes irradiation-induced apoptosis in cervical cancer tissues from patients undergoing chemoradiotherapyHigh level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.Bromodomain factors of BET family are new essential actors of pericentric heterochromatin transcriptional activation in response to heat shockProteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells.Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response.HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.Small molecule activators of the heat shock response: chemical properties, molecular targets, and therapeutic promise.The SIRT1 modulators AROS and DBC1 regulate HSF1 activity and the heat shock response.The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.Overexpression of Heat Shock Transcription Factor 1 enhances the resistance of melanoma cells to doxorubicin and paclitaxel.Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic fluxHSF1 functions as a transcription regulator for Dp71 expression.FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification.Mutant p53 - Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival.The crossroads between cancer stem cells and aging.The unpredictability of prolonged activation of stress response pathways.Using the heat-shock response to discover anticancer compounds that target protein homeostasis.Molecular chaperones in mammary cancer growth and breast tumor therapyHeat shock factor 1 induces cancer stem cell phenotype in breast cancer cell linesHeat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart.Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness.RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy.Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis.Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients
P2860
Q24311618-9B92B8AD-9406-4CCF-9258-D00910301C17Q26777412-7D639225-08E6-416C-8AB6-6A0F445D982DQ27010679-0C406826-160A-47CE-92CC-73D72878519BQ27309985-06CF0830-C7DF-4A93-9643-EF52F6C804C9Q28115805-24285322-94E9-4132-BFD8-C5598657163AQ28116279-A1193E73-C88A-41D0-A34A-F508796EE632Q28118867-B7A9B365-26F7-4B53-B4D6-3B897CA6B4D7Q28272905-E86652EB-0AB0-46B4-93C4-355B2D243593Q28392605-3006BBB9-3AAA-46CB-BA7C-AF2E2420A535Q28829297-8FD0956A-60D8-479A-A67D-62FAD67219CBQ30587039-5A8FFCF1-2666-456D-A6EA-E9E57522F784Q33597951-C69439A5-02AF-4342-9346-6C2DE9BFD2DFQ33694931-52EA7700-E0A9-4D90-9CE1-9B2A1C967BFCQ33762944-931601A2-3C75-4D4B-9098-4C90CD8C819CQ33829519-AFF7091E-5399-4E6A-903E-AE19429BB700Q33877440-ADCFBD63-3E19-497F-B597-CA196B3477FBQ33905708-2FE39639-A895-46B1-914F-E1433D8661FEQ33952834-7BDE816F-F54B-4688-9E76-FA2DEE66E98FQ33955293-E1BC9C65-5F7D-4BAA-ABCB-A47D306DB142Q34100283-EDD58CE4-7CEF-4097-A468-66357ADE944BQ34292197-1AF117B0-3813-4D8B-9E8C-CBA0C692A345Q34338604-89D90CC3-6CA2-47B1-8991-2AE3F86D5FD2Q34562970-0EF379B3-68B3-43A1-94A0-F1EB23622BF9Q34599918-B50EB425-4A46-4F0F-A939-D2D2CD7285A2Q34765945-EC1D9F44-905D-418C-97F4-403BF1EF0293Q35027276-6175EF21-5D5C-4F26-A26D-6D11025BF76EQ35057071-2057BFBA-310B-45B9-95C4-695D57A3447CQ35078823-49822CC4-7271-4DF0-A786-7854699086E2Q35463880-24A9652D-04D9-47F9-B022-5C20F9F196FEQ35522196-8F2C04B5-3D3F-4193-8DAB-FD1173C9118AQ35566484-C624748C-A696-4D33-B322-BF0BBA6214E6Q35771415-4A190031-D47B-4FBA-81D6-1BF3EBD9AD83Q35794082-D8AB5542-0D4B-448A-9248-614FCC5A109EQ35843133-5B896C89-EC92-4A35-8209-75663840F3DDQ35952617-68F7C6B5-B0A6-455A-8588-C043A2572FF4Q36061338-32C00885-B057-44CC-9B6E-5BEF0B70BD4FQ36065078-CE293048-5E82-475F-B847-112AED11F266Q36111622-645F47B5-5F7A-4A0B-8870-C9A5DB6F2DEDQ36200335-83794189-8827-4072-9C84-3C0D4FC8C35EQ36223509-11D1C4D0-A6E4-4FF9-B364-A6B1B88E10BB
P2860
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@ast
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@en
type
label
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@ast
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@en
prefLabel
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@ast
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@en
P2093
P2860
P50
P356
P1476
High levels of nuclear heat-sh ...... or prognosis in breast cancer.
@en
P2093
Laura C Collins
Nancy U Lin
Rulla M Tamimi
Sandro Santagata
Stuart J Schnitt
Susan E Hankinson
Tan A Ince
P2860
P304
18378-18383
P356
10.1073/PNAS.1115031108
P407
P577
2011-10-31T00:00:00Z